News FocusCANCER

Encouraging Results for Second-Generation Antiangiogenesis Drugs

Science  27 May 2005:
Vol. 308, Issue 5726, pp. 1248-1249
DOI: 10.1126/science.308.5726.1248

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

The strategy of denying growing tumors a blood supply continues to show clinical promise as new and improved drugs move through the pipeline.

Related Content